Rebalance’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Sell |
590
-5
| -0.8% | -$3.9K | 0.03% | 78 |
|
|
2025
Q1 | $492K | Buy |
595
+8
| +1% | +$6.61K | 0.04% | 72 |
|
|
2024
Q4 | $453K | Sell |
587
-8
| -1% | -$6.18K | 0.03% | 76 |
|
|
2024
Q3 | $527K | Sell |
595
-76
| -11% | -$67.3K | 0.04% | 66 |
|
|
2024
Q2 | $608K | Buy |
671
+8
| +1% | +$7.24K | 0.05% | 60 |
|
|
2024
Q1 | $516K | Sell |
663
-45
| -6% | -$35K | 0.04% | 64 |
|
|
2023
Q4 | $413K | Sell |
708
-5
| -0.7% | -$2.92K | 0.04% | 68 |
|
|
2023
Q3 | $383K | Buy |
713
+3
| +0.4% | +$1.61K | 0.04% | 64 |
|
|
2023
Q2 | $333K | Sell |
710
-3
| -0.4% | -$1.41K | 0.03% | 65 |
|
|
2023
Q1 | $245K | Sell |
713
-43
| -6% | -$14.8K | 0.02% | 72 |
|
|
2022
Q4 | $277K | Buy |
+756
| New | +$277K | 0.03% | 71 |
|